Skip to content

IV Paracetamol Versus IV Dexketoprofen in Dysmenorrhea

Intravenous Paracetamol Versus Intravenous Dexketoprofen in Patients Presented With Dysmenorrhea in Emergency Department

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02373514
Enrollment
100
Registered
2015-02-27
Start date
2015-01-31
Completion date
2015-03-31
Last updated
2015-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysmenorrhea

Brief summary

Patients presented with dysmenorrhea composed the study population. One gram paracetamol and 50 mg dexketoprofen in 100 ml saline with a rapid infusion were compared in ceasing dysmenorrhea in emergency department.

Detailed description

Patients over 18 years old who presented with dysmenorrhea composed the study population. Patients received pain killer within the last six hours, physical findings consistent with peritoneal irritation, allergy to the study drugs, renal or liver failure, drug addiction, pregnancy or woman with lactation and denied to give inform consent were the exclusion criteria. The pain of the study patients are measured with visual analogue scale at baseline, 15th and 30th minutes. At the end of the 30 minutes, rescue drug need is also recorded.

Interventions

DRUGParacetamol

1 gr paracetamol in 100 ml saline with rapid infusion

DRUGDexketoprofen

50 mg dexketoprofen in 100 ml saline with rapid infusion

Sponsors

Akdeniz University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with dysmenorrhea * Patients over 18 years old

Exclusion criteria

* denied to give inform consent * Renal or liver failure * Allergy to the study drugs * Receiving pain killer within the last 6 hours. * Physical examination findings consistent with peritoneal irritation * Pregnancy or patients with lactation * Drug addiction

Design outcomes

Primary

MeasureTime frameDescription
Visual Analogue Scale15 minutesChange in visual analogue scale at 15th minutes from baseline

Secondary

MeasureTime frame
Rescue drug need30 minutes
Adverse effects30 minutes

Countries

Turkey (Türkiye)

Contacts

Primary ContactCenker Eken, Medical Doctor
cenkereken@akdeniz.edu.tr0090 532 1593948
Backup ContactMustafa Serinken, MD
aserinken@hotmail.com0090 505 2991497

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026